Literature DB >> 15961389

G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes.

Brian P Head1, Hemal H Patel, David M Roth, N Chin Lai, Ingrid R Niesman, Marilyn G Farquhar, Paul A Insel.   

Abstract

This study tests the hypothesis that G-protein-coupled receptor (GPCR) signaling components involved in the regulation of adenylyl cyclase (AC) localize with caveolin (Cav), a protein marker for caveolae, in both cell-surface and intracellular membrane regions. Using sucrose density fractionation of adult cardiac myocytes, we detected Cav-3 in both buoyant membrane fractions (BF) and heavy/non-buoyant fractions (HF); beta2-adrenergic receptors (AR) in BF; and AC5/6, beta1-AR, M4-muscarinic acetylcholine receptors (mAChR), mu-opioid receptors, and Galpha(s) in both BF and HF. In contrast, M2-mAChR, Galpha(i3), and Galpha(i2) were found only in HF. Immunofluorescence microscopy showed co-localization of Cav-3 with AC5/6, Galpha(s), beta2-AR, and mu-opioid receptors in both sarcolemmal and intracellular membranes, whereas M2-mAChR were detected only intracellularly. Immunofluorescence of adult heart revealed a distribution of Cav-3 identical to that in isolated adult cardiac myocytes. Upon immunoelectron microscopy, Cav-3 co-localized with AC5/6 and Galpha(s) in sarcolemmal and intracellular vesicles, the latter closely allied with T-tubules. Cav-3 immunoprecipitates possessed components that were necessary and sufficient for GPCR agonist-promoted stimulation and inhibition of cAMP formation. The distribution of GPCR, G-proteins, and AC with Cav-3 in both sarcolemmal and intracellular T-tubule-associated regions indicates the existence of multiple Cav-3-localized cellular microdomains for signaling by hormones and drugs in the heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961389     DOI: 10.1074/jbc.M502540200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  101 in total

1.  Caveolin modulates integrin function and mechanical activation in the cardiomyocyte.

Authors:  Sharon Israeli-Rosenberg; Chao Chen; Ruixia Li; Daniel N Deussen; Ingrid R Niesman; Hideshi Okada; Hemal H Patel; David M Roth; Robert S Ross
Journal:  FASEB J       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

3.  Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.

Authors:  R I Hussain; F Afzal; H K Mørk; J M Aronsen; I Sjaastad; J-B Osnes; T Skomedal; F O Levy; K A Krobert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

Review 5.  Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions.

Authors:  J A Johnson; S B Liggett
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

Review 6.  Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability.

Authors:  Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-03       Impact factor: 3.000

7.  Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8.

Authors:  Agnes C L Martin; Debbie Willoughby; Antonio Ciruela; Laura-Jo Ayling; Mario Pagano; Sebastian Wachten; Anders Tengholm; Dermot M F Cooper
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

8.  Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Ellen M Unterwald; Lee-Yuan Liu-Chen
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

9.  Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor.

Authors:  Peng Huang; Chongguang Chen; Wei Xu; Su-In Yoon; Ellen M Unterwald; John E Pintar; Yulin Wang; Parkson Lee-Gau Chong; Lee-Yuan Liu-Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-10-31       Impact factor: 3.575

10.  Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.

Authors:  Brian P Head; Hemal H Patel; Ingrid R Niesman; John C Drummond; David M Roth; Piyush M Patel
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.